Clinical Trial Update: Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abemaciclib in combination with FOLFOX/FOLFIRI for patients with advanced colorectal liver metastases; currently enrolling by invitatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastasis From Colorectal Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• FOLFOX

Snippet

Sponsor: Fudan University | Conditions: Liver Metastases From Colorectal Cancer (mCRC) | Phase 2 | Status: ENROLLING_BY_INVITATION